Dissolution of fine particle fraction from truncated Anderson cascade impactor with an enhancer cell

    loading  Checking for direct PDF access through Ovid


Dissolution testing for inhalers were previously conducted either on unfractionated drug-carrier powders or drug of specific aerodynamic particle size. In this study, the collection of the full fine particle fraction (FPF) was attempted on a single stage. Capsules containing 30mg of 2% salbutamol sulfate (SS) was tested to have a FPF of 9±1% using the full set of Andersen cascade impactor (ACI) and a modified Rotahaler® capable of achieving 4.0kPa pressure drop at 60L/min air flow rate. A truncated ACI comprising the USP throat, pre-separator, stage 0, stage 4, stage F, polytetrafluoroethylene funnel (TF) and small collection plate (sCP) was found to be capable of achieving a FPF of 9% collected on TF and sCP. An adhesive tape was used to collect the FPF from the TF and sCP and held in place by an enhancer cell in a 200mL round bottom vessel containing 50mL Gamble’s solution with 0.2 v/v, % Tween 80. Dissolution testing of SS and Seretide® showed burst release of SS and salmeterol while sustained release of fluticasone. This study demonstrated a reproducible method which may be used for evaluation of the full FPF of orally inhaled products.

    loading  Loading Related Articles